SSSwaminathan Sethuraman

Swaminathan Sethuraman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Swaminathan Sethuraman has a total of 90 co-authors. Here are the top co-authors by number of shared publications:

  • Uma Maheswari Krishnan

    27 shared publications
  • Anuradha Subramanian

    Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials, ABCDE Innovation Centre, School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, 613401, India

    26 shared publications
  • Dhakshinamoorthy Sundaramurthi

    Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials, ABCDE Innovation Centre, School of Chemical & Biotechnology, SASTRA Deemed University, India

    12 shared publications
  • Uma Maheswari Krishnan

    Centre for Nanotechnology & Advanced Biomaterials (CeNTAB), School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur 613 401, Tamil Nadu, India

    8 shared publications
  • Dhakshinamoorthy Sundaramurthi

    Tissue Engineering & Additive Manufacturing (TEAM) Lab, Centre for Nanotechnology & Advanced Biomaterials (CeNTAB), ABCDE Innovation Centre, School of Chemical & Biotechnology (SCBT), SASTRA Deemed University, Tirumalaisamudram, Thanjavur, India

    5 shared publications
  • Harshavardhan Budharaju

    School of Chemical, Materials and Biological Engineering, University of Sheffield, Mappin Street, Sheffield S1 3JD, U.K.

    5 shared publications

Latest Publications

  • Next-generation hydrogels and strategies to recreate 3D tumour microenvironments for osteosarcoma: from bioprinting to therapeutic testing

    by Satish Kanna Murali, Dona Shaji, Anastasia V. Sochilina, Tatiana Egorova, Swaminathan Sethuraman, Roman A. Akasov, Dhakshinamoorthy Sundaramurthi

    Hydrogel based in vitro models and adjuvant therapies for osteosarcoma. The image is modified from Servier Medical Art (https://smart.servier.com), licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).

  • Development of a low viscosity PEGDA - gelatin bioink for embedded bioprinting of complex structures and lung adenocarcinoma (LUAD) model

    by Aiswarya Ganapathisankarakrishnan, Dona Shaji, Amrutha Krishnamoorthy, Swaminathan Sethuraman, Dhakshinamoorthy Sundaramurthi

  • Fabrication of a hybrid cellularized cardiac patch via 3D bioprinting of alginate-gelatin-PEOz patterns on electrospun PLCL-PEOz nanofibers

    by Muthu Parkkavi Sekar, David Raj Chellappan, Dhakshinamoorthy Sundaramurthi, Swaminathan Sethuraman

    Integrating electrospinning & 3D bioprinting to biofabricate 3D cellular cardiac patches with topographical and cellular cues for improved cardiac regeneration.


  • Advances in 3D Bioprinting of Functional Skeletal Muscle Constructs: Focus on Preclinical Models and Evaluation Strategies

    by Harshavardhan Budharaju, Praveenn Kumar S K, Madhumathi Rajendran, Mahalakshmi Sivasubramanian, Swaminathan Sethuraman, Dhakshinamoorthy Sundaramurthi

    Skeletal muscle is an important organ system of the human body, which is responsible for maintaining body posture and movement and also plays an essential role in metabolic and endocrine functions. Although skeletal muscle has intrinsic regeneration ability, loss exceeding approximately 20% of the mass or volume of an individual muscle is considered volumetric muscle loss (VML), which requires surgical intervention for repair. Tissue engineered scaffolds prepared using techniques such as electrospinning, hydrogel casting, particulate leaching, freeze-drying, freeze-thawing, and bioprinting are promising for treating VML injuries. In this review, we discuss various extrusion-based bioprinting strategies to fabricate skeletal muscle constructs aimed at treating VML. Further, this review provides a comprehensive overview of various extrusion-based bioprinting techniques to fabricate muscle tissues such as support-based, co-axial, in situ, cryobioprinting, spheroids, and 4D bioprinting. Different bioink systems, their key properties, and similarities with the native extracellular matrix (ECM) are elaborated. In addition, commonly used preclinical models for assessing the efficacy of skeletal muscle constructs, as well as various experimental methods for assessing functional recovery after VML injuries treated with engineered tissue constructs, are discussed. The limitations of current approaches in the successful fabrication of skeletal muscle constructs using bioprinting techniques are highlighted. Finally, the future scope in the development of more efficient experimental tools to assess the in vivo efficacy of bioprinted constructs to treat VML are discussed.


  • Open Access

    Srishti: a custom-built laser-assisted 3D bioprinter for fabricating high-resolution biological constructs

    by Muthu Parkkavi Sekar, Anuradha Subramanian, Dhakshinamoorthy Sundaramurthi, Swaminathan Sethuraman


  • Protein–in–polysaccharide bioink for 3D bioprinting of muscle mimetic tissue constructs to treat volumetric muscle loss

    by Harshavardhan Budharaju, David Raj Chellappan, Dhakshinamoorthy Sundaramurthi, Swaminathan Sethuraman


  • Open Access

    Insights on the role of cryoprotectants in enhancing the properties of bioinks required for cryobioprinting of biological constructs

    by Harshavardhan Budharaju, Dhakshinamoorthy Sundaramurthi, Swaminathan Sethuraman

    Preservation and long-term storage of readily available cell-laden tissue-engineered products are major challenges in expanding their applications in healthcare. In recent years, there has been increasing interest in the development of off-the-shelf tissue-engineered products using the cryobioprinting approach. Here, bioinks are incorporated with cryoprotective agents (CPAs) to allow the fabrication of cryopreservable tissue constructs. Although this method has shown potential in the fabrication of cryopreservable tissue-engineered products, the impact of the CPAs on the viscoelastic behavior and printability of the bioinks at cryo conditions remains unexplored. In this study, we have evaluated the influence of CPAs such as glycerol and dimethyl sulfoxide (DMSO) on the rheological properties of pre-crosslinked alginate bioinks for cryoprinting applications. DMSO-incorporated bioinks showed a reduction in viscosity and yield stress, while the addition of glycerol improved both the properties due to interactions with the calcium chloride used for pre-crosslinking. Further, tube inversion and printability experiments were performed to identify suitable concentrations and cryobioprinting conditions for bioinks containing CPAs & pre-crosslinked with CaCl2. Finally, based on the printability analysis & cell recovery results, 10% glycerol was used for cryobioprinting and preservation of cell-laden constructs at −80 °C and the viability of cells within the printed structures were evaluated after recovery. Cell viability results indicate that the addition of 10% glycerol to the pre-crosslinked bioink significantly improved cell viability compared to bioinks without CPAs, confirming the suitability of the developed bioink combination to fabricate tissue constructs for on-demand applications. Graphical abstract Effect of cryoprotectants on the viscoelastic behavior of bioinks and cell recovery in cryobioprinted tissue constructs.


  • Fabrication of Anatomically Equivalent Pectin-Based Multifilament Nerve Conduits

    by Preethy Amruthavarshini Ramesh, Swaminathan Sethuraman, Anuradha Subramanian

    Reuniting denuded nerve ends after a long segmental peripheral nerve defect is challenging due to delayed axonal regeneration and incomplete, nonspecific reinnervation, as conventional hollow nerve guides fail to ensure proper fascicular complementation and obstruct axonal guidance across the defects. This study focuses on fabricating multifilament conduits using a plant-derived anionic polysaccharide, pectin, where the abundant availability of carboxylate (COO-) functional groups in pectin facilitates instantaneous sol-gel transition upon interaction with divalent cations. Despite their advantages, pectin hydrogels encounter structural instability under physiological conditions. Hence, pectin is conjugated with light-sensitive methacrylate residues (49.8% methacrylation) to overcome these issues, enabling the fabrication of dual cross-linked multifilament nerve conduits through an ionic interaction-driven, template-free 3D wet writing process, followed by photo-cross-linking at 525 nm. The anatomical equivalence including peri-, epi-, and endoneurium structures of the customized multifilament conduits was confirmed through scanning electron micrographs and micro-CT analysis of rat and goat sciatic nerve tissues. Furthermore, the fabricated multifilament nerve conduits demonstrated cytocompatibility and promoted the expression of neuron-specific intermediate filament protein (NF-200) in PC12 cells and neurite outgrowth of 16.90 ± 1.82 μm on day 14. Micro-CT imaging of an anastomosed native goat sciatic nerve with an 8-filament conduit demonstrated precise fascicular complementation in an ex vivo interpositional goat model. This approach not only eliminates the need for a suture-intensive ligation process but also highlights the customizability of multifilament conduits to meet patient- and injury-specific needs.


  • Biofabrication & cryopreservation of tissue engineered constructs for on-demand applications

    by Harshavardhan Budharaju, Dhakshinamoorthy Sundaramurthi, Swaminathan Sethuraman

    Tissue engineered constructs prepared using conventional scaffold-based approaches have the potential to repair or regenerate damaged tissues and organs. Various scaffold fabrication strategies such as electrospinning, solvent casting, particulate leaching, gas foaming, hydrogels, freeze-drying, and 3D bioprinting have been used to fabricate artificial tissues. In recent times, 3D bioprinting has been predominantly used in various biomedical fields, including healthcare and pharmaceutical applications due to precision in 3D geometry. However, there are no viable strategies to preserve bioprinted constructs for on-demand applications because of the lack of specialized techniques or cryopreservation agents to maintain the cell viability and functionality of the bioprinted tissues. To solve this issue, cryopreservation of bioprinted tissues has emerged in recent years to develop methods to create and cryopreserve bioprinted constructs for on-demand applications. This review discusses various techniques used for producing ready-to-use tissue engineered products such as electrospinning, hydrogels, 3D bioprinting, and other bioprinting approaches. Further, the factors influencing the bioprinted tissues, such as cryoprotectants, polymer types and crosslinker concentrations, crosslinking approaches, viscoelastic properties, storage facilities, etc, were also discussed in detail. The potential of cryopreservable bioprinted tissues in various healthcare applications are elaborated with lucid examples. Finally, the conclusions and possible future directions for the fabrication and cryopreservation of tissue engineered products are highlighted.


  • Open Access

    Preparation of Thermoresponsive & Enzymatically Crosslinkable Gelatin-Gellan Gum Bioink: A Protein-Polysaccharide Hydrogel for 3d Bioprinting of Complex Soft Tissues

    by Shambhavi Bagewadi, Madhumathi Rajendran, Aiswarya Ganapathisankarakrishnan, Harshavardhan Budharaju, Swaminathan Sethuraman, Dhakshinamoorthy Sundaramurthi

    A new combination of gelatin (GL)-gellan gum (GG) bioink was successfully formulated and demonstrated to have excellent printability and shape fidelity. Three different combinations of gelatin-gellan gum (5GL/2GG, 7.5GL/2GG and 10GL/2GG) composite bioinks were developed. Based on rheological properties, 7.5GL/2GG bioink was found optimal for extrusion 3D bioprinting. Post-bioprinting, the GL/GG constructs were enzymatically crosslinked using 10% transglutaminase (TG) for 3 h. To check the efficacy of TG crosslinking, GL/GG constructs were crosslinked with only CaCl2 (0.3 M) for 30 minutes and also dual crosslinked with CaCl2 (0.3 M) for 30 minutes followed by TG crosslinking for 2.5 h. Direct and indirect cytotoxicity assays for the developed bioink was carried out using human dermal fibroblasts (HDFa) and human adult immortalized keratinocytes (HaCaT) cell lines. It was found that the crosslinked constructs were cytocompatible and showed higher cell viability (>70 %) as per the ISO 10993-5. The 3D bioprinted GL/GG constructs crosslinked with only TG showed better cell viability, proliferation and cell spreading compared to dual crosslinked constructs. Further, 7.5GL/2GG bioink with TG crosslinking was found to be ideal for printing complex and highly intricate structures with excellent shape fidelity for regenerative medicine and drug screening applications.